Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 165

1.

Testosterone improves antidepressant-emergent loss of libido in women: findings from a randomized, double-blind, placebo-controlled trial.

Fooladi E, Bell RJ, Jane F, Robinson PJ, Kulkarni J, Davis SR.

J Sex Med. 2014 Mar;11(3):831-9. doi: 10.1111/jsm.12426. Epub 2014 Jan 16.

PMID:
24433574
2.

Safety and efficacy of a testosterone metered-dose transdermal spray for treating decreased sexual satisfaction in premenopausal women: a randomized trial.

Davis S, Papalia MA, Norman RJ, O'Neill S, Redelman M, Williamson M, Stuckey BG, Wlodarczyk J, Gard'ner K, Humberstone A.

Ann Intern Med. 2008 Apr 15;148(8):569-77.

PMID:
18413618
3.

Testosterone for low libido in postmenopausal women not taking estrogen.

Davis SR, Moreau M, Kroll R, Bouchard C, Panay N, Gass M, Braunstein GD, Hirschberg AL, Rodenberg C, Pack S, Koch H, Moufarege A, Studd J; APHRODITE Study Team.

N Engl J Med. 2008 Nov 6;359(19):2005-17. doi: 10.1056/NEJMoa0707302.

4.

Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.

Davis SR, van der Mooren MJ, van Lunsen RH, Lopes P, Ribot C, Rees M, Moufarege A, Rodenberg C, Buch A, Purdie DW.

Menopause. 2006 May-Jun;13(3):387-96. Erratum in: Menopause. 2006 Sep-Oct;13(5):850. Ribot, Jean [corrected to Ribot, Claude].

PMID:
16735935
5.

Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder.

Kingsberg S, Shifren J, Wekselman K, Rodenberg C, Koochaki P, Derogatis L.

J Sex Med. 2007 Jul;4(4 Pt 1):1001-8.

PMID:
17627745
6.
7.

A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction.

Clayton AH, Warnock JK, Kornstein SG, Pinkerton R, Sheldon-Keller A, McGarvey EL.

J Clin Psychiatry. 2004 Jan;65(1):62-7.

PMID:
14744170
8.

Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder.

Simon J, Braunstein G, Nachtigall L, Utian W, Katz M, Miller S, Waldbaum A, Bouchard C, Derzko C, Buch A, Rodenberg C, Lucas J, Davis S.

J Clin Endocrinol Metab. 2005 Sep;90(9):5226-33. Epub 2005 Jul 12.

PMID:
16014407
9.

Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial.

Buster JE, Kingsberg SA, Aguirre O, Brown C, Breaux JG, Buch A, Rodenberg CA, Wekselman K, Casson P.

Obstet Gynecol. 2005 May;105(5 Pt 1):944-52.

PMID:
15863529
10.

Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women.

Goldstat R, Briganti E, Tran J, Wolfe R, Davis SR.

Menopause. 2003 Sep-Oct;10(5):390-8.

PMID:
14501599
11.

Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.

Braunstein GD, Sundwall DA, Katz M, Shifren JL, Buster JE, Simon JA, Bachman G, Aguirre OA, Lucas JD, Rodenberg C, Buch A, Watts NB.

Arch Intern Med. 2005 Jul 25;165(14):1582-9.

PMID:
16043675
12.

Testosterone treatment for hypoactive sexual desire disorder in postmenopausal women.

Kingsberg S.

J Sex Med. 2007 Mar;4 Suppl 3:227-34. Review.

PMID:
17394595
13.

Efficacy of flibanserin in women with hypoactive sexual desire disorder: results from the BEGONIA trial.

Katz M, DeRogatis LR, Ackerman R, Hedges P, Lesko L, Garcia M Jr, Sand M; BEGONIA trial investigators.

J Sex Med. 2013 Jul;10(7):1807-15. doi: 10.1111/jsm.12189. Epub 2013 May 14.

PMID:
23672269
14.

Sildenafil treatment of women with antidepressant-associated sexual dysfunction: a randomized controlled trial.

Nurnberg HG, Hensley PL, Heiman JR, Croft HA, Debattista C, Paine S.

JAMA. 2008 Jul 23;300(4):395-404. doi: 10.1001/jama.300.4.395.

PMID:
18647982
15.

Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido; North Central Cancer Treatment Group protocol N02C3.

Barton DL, Wender DB, Sloan JA, Dalton RJ, Balcueva EP, Atherton PJ, Bernath AM Jr, DeKrey WL, Larson T, Bearden JD 3rd, Carpenter PC, Loprinzi CL.

J Natl Cancer Inst. 2007 May 2;99(9):672-9.

16.

Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder.

Clayton A, Kornstein S, Prakash A, Mallinckrodt C, Wohlreich M.

J Sex Med. 2007 Jul;4(4 Pt 1):917-29.

PMID:
17627739
17.

Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study.

Shifren JL, Davis SR, Moreau M, Waldbaum A, Bouchard C, DeRogatis L, Derzko C, Bearnson P, Kakos N, O'Neill S, Levine S, Wekselman K, Buch A, Rodenberg C, Kroll R.

Menopause. 2006 Sep-Oct;13(5):770-9. Erratum in: Menopause. 2007 Jan-Feb;14(1):157.

PMID:
16932240
18.

SAMe and sexual functioning.

Dording CM, Mischoulon D, Shyu I, Alpert JE, Papakostas GI.

Eur Psychiatry. 2012 Aug;27(6):451-4. doi: 10.1016/j.eurpsy.2011.01.003. Epub 2011 Mar 12.

PMID:
21398094
20.

Testosterone gel replacement improves sexual function in depressed men taking serotonergic antidepressants: a randomized, placebo-controlled clinical trial.

Amiaz R, Pope HG Jr, Mahne T, Kelly JF, Brennan BP, Kanayama G, Weiser M, Hudson JI, Seidman SN.

J Sex Marital Ther. 2011;37(4):243-54. doi: 10.1080/0092623X.2011.582425.

PMID:
21707327
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk